Medifend Ovakare Capsule
Medifend Ovakare Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL26056054T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- STELLAR BIO SDN BHD
- Manufacturer
- STELLAR BIO SDN BHD
- Registration period starting
- 2026-05-07
- Published validity end
- 2031-05-07
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Asparagus racemosus | Asparagus racemosus[200 mg,500 mg] | Not identified |
| Vaccinium macrocarpon | Vaccinium macrocarpon[37.50 mg,500 mg] | Not identified |
| Taraxacum officinale | Taraxacum officinale[120 mg,500 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Asparagus racemosus[200 mg,500 mg],Vaccinium macrocarpon[37.50 mg,500 mg],Taraxacum officinale[120 mg,500 mg]
- Valid until
- 2031-05-07
- Registration date
- 2026-05-07
- Published description
- NATURAL PRODUCT
- Licence holder
- STELLAR BIO SDN BHD
- Producer
- STELLAR BIO SDN BHD
- Published name
- Medifend Ovakare Capsule
- Published reference
- 2026010721045T
- Registration number
- MAL26056054T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL26056054T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium macrocarpon
Read the warning, when it applies and the studies cited
CRANBERRY - VACCINIUM MACROCARPON
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
DRIED CRANBERRY JUICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.